HALO
Halozyme Therapeutics Inc.
$65.60
+$1.50(+2.34%)
53
Overall
60
Value
25
Tech
76
Quality
Market Cap
$7.50B
Volume
1.01M
52W Range
$42.01 - $79.50
Target Price
$76.00
Key Metrics Overview
| Market Cap | $7.50B | P/E Ratio | 11.21 |
| 52W High | $79.50 | 52W Low | $42.01 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 7.0% | 52W Position | 62.9% |
| Overall Score | 53 | Value Score | 60 |
| Quality Score | 76 | Technical Score | 25 |
Growth Analysis
| EPS Current Est | $5.85 | EPS Next Est | $7.29 |
| EPS Growth Est | +24.6% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HALO | $65.60 | +2.3% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Halozyme Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW